Rofecoxib-induced pseudoporphyria.
Markus
Ramsey
R
Reddick
Max E
ME
Rubenstein
Melissa C
MC
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000188:drug therapy; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D011164:Porphyrias / Q000139:chemically induced*; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib